55 related articles for article (PubMed ID: 34582659)
1. Long non-coding RNAs PTENP1, GNG12-AS1, MAGI2-AS3 and MEG3 as tumor suppressors in breast cancer and their associations with clinicopathological parameters.
Záveský L; Jandáková E; Weinberger V; Minář L; Kohoutová M; Slanař O
Cancer Biomark; 2024; 40(1):61-78. PubMed ID: 38277283
[TBL] [Abstract][Full Text] [Related]
2. Expression analysis of PPAR-related lncRNAs in breast cancer.
Ghafouri-Fard S; Nicknam A; Safarzadeh A; Eslami S; Samsami M; Jamali E
Pathol Res Pract; 2023 Nov; 251():154844. PubMed ID: 37820438
[TBL] [Abstract][Full Text] [Related]
3. CBR3-AS1 Accelerates the Malignant Proliferation of Gestational Choriocarcinoma Cells by Stabilizing SETD4.
Zhang Y; Zhang H; Zhang X; Liu B
Dis Markers; 2022; 2022():7155525. PubMed ID: 35655916
[TBL] [Abstract][Full Text] [Related]
4. Identification of long noncoding RNAs downregulated specifically in ovarian high-grade serous carcinoma.
Hayashi-Okada M; Sato S; Nakashima K; Sakai T; Tamehisa T; Kajimura T; Tamura I; Sueoka K; Sugino N
Reprod Med Biol; 2024; 23(1):e12572. PubMed ID: 38571514
[TBL] [Abstract][Full Text] [Related]
5. LncRNAs AK058003 and MVIH Overexpression in the Blood Samples of Iranian Breast Cancer Patients.
Akhavan Attar F; Oloomi M; Irani S; Azizi M; Geranpayeh L
Iran Biomed J; 2021 Mar; 25(2):93-8. PubMed ID: 33462225
[TBL] [Abstract][Full Text] [Related]
6. In silico identification of MAPK14-related lncRNAs and assessment of their expression in breast cancer samples.
Dashti S; Taherian-Esfahani Z; Kholghi-Oskooei V; Noroozi R; Arsang-Jang S; Ghafouri-Fard S; Taheri M
Sci Rep; 2020 May; 10(1):8316. PubMed ID: 32433496
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of
Molaei Ramshe S; Ghaedi H; Omrani MD; Geranpayeh L; Alipour B; Ghafouri-Fard S
Heliyon; 2021 Oct; 7(10):e08179. PubMed ID: 34703931
[TBL] [Abstract][Full Text] [Related]
8. Retracted: CBR3-AS1 Accelerates the Malignant Proliferation of Gestational Choriocarcinoma Cells by Stabilizing SETD4.
Markers D
Dis Markers; 2023; 2023():9830426. PubMed ID: 37829125
[TBL] [Abstract][Full Text] [Related]
9. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
[TBL] [Abstract][Full Text] [Related]
10. TTN-AS1 as a potential diagnostic and prognostic biomarker for multiple cancers.
Zheng QX; Wang J; Gu XY; Huang CH; Chen C; Hong M; Chen Z
Biomed Pharmacother; 2021 Mar; 135():111169. PubMed ID: 33433359
[TBL] [Abstract][Full Text] [Related]
11. Long Non-Coding RNAs Expression in Breast Cancer: CBR3-AS1 LncRNA as a Sensitive Biomarker.
Torkashvand S; Basi A; Ajdarkosh H; Rakhshani N; Nafisi N; Mowla SJ; Moghadas A; Mohammadipour M; Karbalaie Niya MH
Asian Pac J Cancer Prev; 2021 Sep; 22(9):2897-2902. PubMed ID: 34582659
[TBL] [Abstract][Full Text] [Related]
12. LncRNA CBR3-AS1 regulates of breast cancer drug sensitivity as a competing endogenous RNA through the JNK1/MEK4-mediated MAPK signal pathway.
Zhang M; Wang Y; Jiang L; Song X; Zheng A; Gao H; Wei M; Zhao L
J Exp Clin Cancer Res; 2021 Jan; 40(1):41. PubMed ID: 33494806
[TBL] [Abstract][Full Text] [Related]
13. Potential role of RAB6C-AS1 long noncoding RNA in different cancers.
Salavaty A; Motlagh FM; Barabadi M; Cheshomi H; Esmatabadi MJD; Shahmoradi M; Soleimanpour-Lichaei HR
J Cell Physiol; 2018 Jan; 234(1):891-903. PubMed ID: 30076712
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of long non-coding RNA ZEB2-AS1 and EMT-related markers in ductal and lobular breast cancer.
Zarei M; Malekzadeh K; Omidi M; Mousavi P
Cancer Rep (Hoboken); 2023 May; 6(5):e1826. PubMed ID: 37088469
[TBL] [Abstract][Full Text] [Related]
15. LncRNA CBR3-AS1 predicts unfavorable prognosis and promotes tumorigenesis in osteosarcoma.
Zhang Y; Meng W; Cui H
Biomed Pharmacother; 2018 Jun; 102():169-174. PubMed ID: 29554595
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]